Bruce-ChwattL.J., & de ZuletaJ. (1980). The rise and fall of Malaria in Europe.Oxford: Oxford University Press.
2.
ButcherC.A. (2002). Development of a train: The trainer program for workers/travelers at risk for malaria. Paper presented at the SPE International Conference on Health, Safety and Environment in Oil and Gas Exploration, Kuala Lumpur, Malaysia.
3.
ButcherC.A. (2004). International health program preventing health problems associated with living abroad.AAOHN Journal, 52(2), 77–85.
4.
Centers for Disease Control and Prevention. (1999). Health information for the international traveler—1999 to 2000.Atlanta. GA: U.S. Department of Health and Human Services.
Centers for Disease Control and Prevention. (2003). Protection against mosquitoes and other arthropods. Retrieved April 27, 2004, from http://www.cdc.gov/travel/bugs.htm#repellents
CoatneyG., CollinsR.E., & WarrenM. (1971). The primate malarias.Bethesda, MD: U.S. Department of Health and Welfare.
9.
ConnorB. (2001). Expert recommendations for antimalarial prohylaxis.Journal of Travel Medicine, 8(3), 62.
10.
DorseyG., GandhiM., OyugiJ.H., & RosenthalP.J. (2000). Difficulties in the prevention, diagnosis, and treatment of imported malaria.Archives of Internal Medicine, 160, 2505–2510.
11.
HarinasutaT., KarbwantJ., & BunnagD. (1997). Treatment of malaria. In DupontH.L., & SteffenR. (Eds.), Textbook of travel medicine and health (pp. 125). Hamilton, Canada: B.C. Decker, Inc.
12.
JongE. C., & NothdurftH.D. (2001). Current drugs for antimalarial chemoprophylaxis: A review of efficacy and safety.Journal of Travel Medicine, 8(3), 51–52, 54.
13.
KainK.C. (2003). Atovaquone/Proguanil: The need for family protection.Journal of Travel Medicine, 10(1), 8.
14.
KainK.C., HarringtonM.A., TennysonS., & KeystoneJ.S. (1998). Imported malaria: Prospective analysis of problems in diagnosis and management.Clinical Infectious Diseases, 27, 142–149.
15.
KainK.C., ShanksG.D., & KeystoneJ.S. (2001). Malaria chemoprophylaxis in the age of drug resistance. I. Currently recommended drug regiments.Clinical Infectious Diseases, 33, 226–234.
16.
KeystoneJ.S. (2001). Reemergence of malaria: Increasing risk for travelers.Journal of Travel Medicine, 8(3), 42–46.
17.
KeystoneJ., & RodriguezB. (Eds.). (2003). Medical reference guide: Travel health information service (6th ed., p. 2). Milwaukee, WI: Shoreland, Inc.
18.
LobelH., KozarskyP.E., & Von SonnenburgF. (1997). Malaria: Chemoprophylaxis. In DupontH.L., & SteffenR. (Eds.), Textbook of travel medicine and health (pp. 112). Hamilton, Canada: B.C. Decker, Inc.
19.
MoranK.A., & KesterK.E. (2001). Malaria vaccines. In SchlagenhaufP. (Ed.), Traveler's Malaria (pp. 474–490). Hamilton, Canada: B.C. Decker, Inc.
NchindaT.C. (1998). Malaria: A remerging disease in Africa.Geneva, Switzerland: World Health Organization.
22.
OverboschD. (2003). Post-marketing surveillance: Adverse events during long-term use of atovaquone/proguanil for travelers to malaria-endemic countries.Journal of Travel Medicine, 10(1), 16–17.
23.
PatarroyoM.E., AmadorR., & MurphyJ.R. (1997). Malaria vaccines. In DupontH.L., & SteffenR. (Eds.), Textbook of travel medicine and health (pp. 137). Hamilton, Canada: B.C. Decker.
RoseS.R. (2001). Malaria. In KeystoneJ., KozarskyP., BiaF.J., ConnorB.A., FradinM.S., NewmanK., & ThompsonR. (Eds.), International travel health guide (12th ed., pp. 96–97, 105, 115). Northhampton, MA: Travel Medicine, Inc.
26.
SchlagenhaufP. (2001a). Drugs used in malaria chemoprophylaxis: Mefloquine. In SchlagenhaufP. (Ed.), Travelers Malaria (pp. 188). Hamilton, Canada: B.C. Decker, Inc.
27.
SchlagenhaufP. (2001b). Travelers’ Malaria: Some historic perspectives. In SchlagenhaufP. (Ed.), Travelers Malaria (pp. 3). Hamilton, Canada: B.C. Decker, Inc.
28.
ShanksG.D. (2001a). Drugs used in malaria chemoprophylaxis: Atovaquone/proguanil. In SchlagenhaufP. (Ed.), Textbook of travelers Malaria (pp. 241). Hamilton, Canada: B.C. Decker, Inc.
29.
ShanksG.D., KainK.C., & KeystoneJ.S. (2001b). Malaria chemoprophylaxis in the age of drug resistance. II. Drugs that may be available in the future.Clinical Infectious Diseases, 33, 381–385.
30.
SteffenR. (2003). Malaria prophylaxis: Setting the scene.Journal of Travel Medicine, 10(1), 3, 7.
31.
SturchlerD. (2001). Global epidemiology of Malaria. In SchlagenhaufP. (Ed.)., Textbook of travelers Malaria (pp. 38). Hamilton, Canada: B.C. Decker, Inc.
32.
ThomasC.L. (Ed.). (1977). Taber cyclopedic medical dictionary (13th ed.). Philadelphia, PA: F.A. Davis Company.
33.
WanerS., BakerL., WolfaardtD.C., DurrheimD.N., & SowesterJ. (2003). Risk factors and characteristics of patients with acute Plasmodium falciparum malaria presenting to a private hospital network in South Africa.Journal of Travel Medicine, 10, 296–298.
34.
WeberR., SchlagenhaufP., AmslerL., & SteffenR. (2003). Knowledge, attitudes and practices of business travelers regarding malaria risk and prevention.Journal of Travel Medicine, 10, 224.
35.
WhiteN.J., & JongE.C. (1995). Malaria diagnosis and treatment. In JongE.C., & McMullenR. (Eds.), The travel & tropical medicine manual (2nd ed., pp. 191, 194). Philadelphia, PA: W.B. Saunders.
36.
World Health Organization. (1991). Tropical diseases: Progress in research, 1989–1990. Tenth Programme report.Geneva, Switzerland: Author.
37.
World Health Organization. (2000). International travel and health. Vaccination requirements and health advice 2000.Geneva, Switzerland: Author.
38.
World Health Organization. (2001). 2001-2010 United Nations decade to roll back Malaria.Geneva, Switzerland: Author.
39.
ZuckerR., & CarnevaleJ. (1997). Malaria: Epidemiology and prevention of exposure. In DupontH.L., & SteffenR. (Eds.), Textbook of travel medicine and health (pp. 101–108). Hamilton, Canada: B.C. Decker.